Potential Approval Roche's Avastin in Ovarian Cancer Would Bode Well for Tesaro (TSRO) - Jefferies
Tweet Send to a Friend
Jefferies analyst Eileen Flowers, Ph.D. weighed in on Tesaro (NASDAQ: TSRO) after discussions with Ovarian cancer experts on Niraparib and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
